Exploratory literature indicates altered pro-inflammatory makers IL-6, IL-8, TNF-α, treatment-induced anaemia, hypoalbuminemia, and a reduction in lean muscle mass are associated with the prevalence of CRF [8,23,24,66,67]. This evidence concerns the gene TNF and anemia (phenotype).